Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Kythera Biopharmaceuticals

Biotech & Life Sciences · Calabasas, United States · Founded 2005 · IPO 2012 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Investors

12 investors on Kythera Biopharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Patent intelligence

$13M patent portfolio · 17 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$13M
39.4× smaller than top peer ChemoCentryx ($524M)
17 active patent families
Where Kythera Biopharmaceuticals innovates Deoxycholic acidChemistryOrganic chemistryDesoxycholic acidMedicinal chemistry
Below peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

Kythera Biopharmaceuticals on the five Patsnap quality dimensions

Kythera Biopharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Kythera Biopharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Kythera Biopharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Kythera Biopharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.